Gastric carcinoids: a temporal increase with proton pump introduction

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Surgical Endoscopy

• Publication date

  2005-10-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00464-005-0232-4PMID 16211437
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Updated Population-Based Review of Carcinoid Tumors

  2004cited by this paper
• Use of anti‐secretory medication: a population‐based cohort study

  2004cited by this paper
• A 5‐decade analysis of 13,715 carcinoid tumors

  2003cited by this paper
• Carcinoid tumors of the stomach.

  2003cited by this paper
• Effect of a gastrin/cholecystokinin B receptor antagonist, S-0509, on the omeprazole-induced proliferation of gastric mucosa in rats.

  2003cited by this paper
• Overuse of proton pump inhibitors

  2000cited by this paper
• Cloning and characterization of gastrin receptor from ECL carcinoid tumor of Mastomys natalensis.

  1992cited by this paper
• Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats.

  1986cited by this paper
• Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation

  1986cited by this paper
• Applied Regression Analysis and Other Multivariate Methods

  1978cited by this paper

• The Association Between Proton Pump Inhibitor Use and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review

  2025influential citation
• [Difficulties in diagnosis of neuroendocrine tumors of the gastrointestinal tract].

  2023cites this paper
• Debulking Surgery for Moderately Differentiated Neuroendocrine Gastric Carcinoma – A Case Report and Literature Review

  2020cites this paper
• Нейроэндокринная опухоль как диагностический и прогностический критерий аутоиммунного гастрита

  2020cites this paper
• Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids—What Is the Relationship?

  2020cites this paper
• Changing Disparity of Gastric Cancer Incidence by Histological Types in US Race-Specific Populations

  2020cites this paper
• Neuroendocrine Tumour as a Diagnostic and Prognostic Criterion for Autoimmune Gastritis

  2020cites this paper
• [Gastric neuroendocrine tumors].

  2019cites this paper
• Clinicopathological profile of neuroendocrine tumors of gastrointestinal tract

  2018cites this paper
• Effectiveness of Apricot Grown in Gilgit-Baltistan for the Eradication of Helicobacter pylori Infection

  2018cites this paper
• To those who demand scientific evidence for homeopathy

  2017cites this paper
• Netazepide, a gastrin/cholecystokinin‐2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis

  2017cites this paper
• Acid-suppressing therapies and subsite-specific risk of stomach cancer

  2017cites this paper
• Aos que clamam pelas evidências científicas em homeopatia

  2017cites this paper
• Scientific basis of the homeopathic healing principle in modern pharmacology

  2017cites this paper
• Type 1 Gastric Carcinoid in the Indian Population and Its Association with Multifocal Gastric Atrophy

  2016cites this paper
• ASSOCIAÇÃO MÉDICA BRASILEIRA

  2016cites this paper
• How May Proton Pump Inhibitors Impair Cardiovascular Health?

  2016cites this paper
• Role of computed tomography angiography in detection and staging of small bowel carcinoid tumors.

  2015cites this paper
• Gastric neuroendocrine tumors: prevalence in Europe, USA, and Japan, and rationale for treatment with a gastrin/CCK2 receptor antagonist

  2015influential citation
• Management and Disease Outcome of Type I Gastric Neuroendocrine Tumors: The Mount Sinai Experience

  2015cites this paper
• Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?

  2015cites this paper
• Increasing incidence of duodenal neuroendocrine tumors: Incidental discovery of indolent disease?

  2015influential citation
• Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature.

  2014cites this paper
• Gastric carcinoids (neuroendocrine neoplasms).

  2013cites this paper
• Inhibition of lysosomal enzyme activities by proton pump inhibitors

  2013cites this paper
• Rebound effect of modern drugs: serious adverse event unknown by health professionals.

  2013cites this paper
• Rebound effects of modern drugs: serious adverse events unknown by health professionals*

  2013cites this paper
• Clinicopathological,Histomorphological andImmunohistochemical Study of Neuroendocrine Tumors of Git.

  2013cites this paper
• Multiple gastric G1 neuroendocrine tumors with venous and lymphatic invasion.

  2013cites this paper
• Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531).

  2013cites this paper
• Efeito rebote dos fármacos modernos : evento adverso grave desconhecido pelos profissionais da saúde

  2013cites this paper
• Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis

  2013cites this paper
• Similia similibus curentur: o princípio de cura homeopático fundamentado na farmacologia moderna

  2013cites this paper
• Does neoadjuvant chemotherapy improve outcomes for patients with gastric cancer?

  2012cites this paper
• Gastric NeuroendocrineTumours

  2012cites this paper
• Gastric and duodenal neuroendocrine tumours.

  2012cites this paper
• Current Concepts on Gastric Carcinoid Tumors

  2012cites this paper
• Proton Pump Inhibitors: The Good, the Bad, and the Unwanted

  2012cites this paper
• Management of Gastric Carcinoids (Neuroendocrine Neoplasms)

  2012cites this paper
• Epidemiology of gastroenteropancreatic neuroendocrine tumours.

  2012cites this paper
• Rebound effect of drugs: fatal risk of conventional treatment and pharmacological basis of homeopathic treatment

  2012cites this paper
• Adverse Effects of Long-Term Proton Pump Inhibitor Therapy

  2011cites this paper
• Gender, race, and socioeconomic status affects outcomes after lung cancer resections in the United States.

  2011cites this paper
• Rebound acid hypersecretion after withdrawal of gastric acid suppressing drugs: new evidence of similitude

  2011cites this paper
• Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival.

  2011cites this paper
• Development of type I gastric carcinoid in patients with chronic atrophic gastritis

  2011cites this paper
• Effects of Proton Pump Inhibitors on Atrophic Gastritis and Gastric Cancer: Safe Perspective

  2011cites this paper
• Adverse effects of proton pump inhibitor drugs: clues and conclusions

  2010cites this paper
• A retrospective clinico-pathological analysis of neuroendocrine tumors of the gastrointestinal tract.

  2010cites this paper
• Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma.

  2010cites this paper
• The Roles of Neoadjuvant Radiotherapy and Lymphadenectomy in the Treatment of Esophageal Adenocarcinoma

  2010cites this paper
• Do all patients with carcinoma of the esophagus benefit from treatment at teaching facilities?

  2010cites this paper
• Do racial or socioeconomic disparities exist in lung cancer treatment?

  2010cites this paper
• Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma?

  2010cites this paper
• Carcinoid Tumors of the Gastrointestinal Tract: Trends in Incidence in England Since 1971

  2010cites this paper
• Gastric carcinoids: between underestimation and overtreatment.

  2009cites this paper
• Survival disparities among African American women with invasive bladder cancer in Florida

  2009cites this paper
• African-American and low-socioeconomic status patients have a worse prognosis for invasive ductal and lobular breast carcinoma: do screening criteria need to change?

  2009cites this paper
• Primary solid tumors of the colon and rectum in the pediatric patient: a review of 270 cases.

  2009cites this paper
• Surgery does not adversely affect survival in primary gastrointestinal lymphoma

  2009cites this paper
• Impact of Hospital Volume on Surgical Outcome for Head and Neck Cancer

  2009cites this paper
• Malignant abdominal mesothelioma: Defining the role of surgery

  2009cites this paper
• CHAPTER 21 – Stomach

  2009cites this paper
• Disparities in survival among women with invasive cervical cancer

  2009cites this paper
• Will Patients Benefit from Regionalization of Gynecologic Cancer Care?

  2009cites this paper
• Tumores Neuroendócrinos do Tubo Digestivo: Casuística do IPO do Porto

  2009cites this paper
• Ewing sarcoma demonstrates racial disparities in incidence‐related and sex‐related differences in outcome

  2009cites this paper
• Gastric Neuroendocrine Neoplasia

  2009cites this paper
• Outcomes of malignant CNS ependymomas: an examination of 2408 cases through the Surveillance, Epidemiology, and End Results (SEER) database (1973-2005).

  2009cites this paper
• Skeletal Plasmacytoma: Progression of disease and impact of local treatment; an analysis of SEER database

  2009cites this paper
• Prognostic Factors for Survival in Patients with Epithelioid Sarcoma: 441 Cases from the SEER Database

  2009cites this paper
• Human Gastric Neuroendocrine Neoplasia: Current Pathologic Status

  2009influential citation
• Impact of Teaching Facility Status and High-Volume Centers on Outcomes for Lung Cancer Resection: An Examination of 13,469 Surgical Patients

  2008cites this paper
• African American and poor patients have a dramatically worse prognosis for head and neck cancer

  2008cites this paper
• Defining the Role of Surgery for Primary Gastrointestinal Tract Melanoma

  2008cites this paper
• Endocrine hyperplasia and dysplasia in the pathogenesis of gastrointestinal and pancreatic endocrine tumors.

  2007cites this paper
• A comparison of the effects of gastrin, somatostatin and dopamine receptor ligands on rat gastric enterochromaffin-like cell secretion and proliferation.

  2007cites this paper
• Treatment of gastric carcinoids

  2007cites this paper
• Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry.

  2007cites this paper
• Review article: pathogenesis and management of gastric carcinoid tumours

  2006cites this paper